Self Care Catalysts welcomes Dr Ethan Basch as Medical Advisor

TORONTO, Jan. 23, 2019 /PRNewswire/ - Self Care Catalysts, a digital health company specializing in helping patients with self care through digital therapeutics backed by real-world evidence, is pleased to announce that Dr. Ethan Basch has joined as a Scientific Advisor. Dr. Basch is a world-renowned expert in Oncology and Real World Evidence Outcomes Research and will advise Self Care Catalysts in optimizing their Health Storylines product for the generation of evidence for biomedical sciences and for the next generation of digital therapeutics.

"Dr. Basch as a true luminary in the field patient-centered outcomes research and the emerging science and discipline of self-care backed by real world evidence in oncology," said Grace Castillo-Soyao, CEO of Self Care Catalysts. "The ways in which patients can best manage their conditions is extending the science of medicine and what works in the "real world" beyond clinics and clinical trials. Dr. Basch is one of the best possible experts to help Self Care Catalysts continue to create digital tools and programs to improve patient clinical outcomes and quality of life "

Castillo-Soyao continued, "Dr. Basch is a true pioneer in the field or real world evidence and digital therapeutics. We are thrilled to work with him to drive the science of real world evidence and continue to build pioneering tools for patients."

Basch's research focuses on the use of patient-reported outcomes and novel technologies to measure the impact of interventions on patients' experiences, and to inform decisions. According to Dr. Basch, "There are substantial opportunities to improve care quality, outcomes, and the patient experience with emerging technology-based tools.  It is exciting to see the innovative approaches being developed that can improves the lives of our patients, and how we deliver cancer treatment."

Dr. Basch will work with Self Care Catalysts to focus on how cancer patients can best direct their own care when away from their doctor or health care system. "For oncology patients, most of their time is spent away from health systems, where they and caregivers make decisions and direct care that can enormously impact outcomes," says Castillo-Soyao.

About Ethan Basch
Ethan Basch, MD, MSc, is a practicing oncologist and Director of the Cancer Outcomes Research Program at the University of North Carolina in Chapel Hill. Dr. Basch's research focuses on the use of patient-reported outcomes and novel technologies to measure the impact of interventions on patients' experiences, and to inform decisions. He has served on the Board of Scientific Advisors of the National Cancer Institute and the Board of Directors of the International Society for Quality of Life Research, and is a member of the Board of Directors of the American Society of Clinical Oncology, and Co-Chair of the cancer Care Delivery Research Committee for the Alliance for Clinical Trials in Oncology. His clinical practice focuses on prostate cancer. Dr. Basch received his BA from Brown University, MD from Harvard Medical School, MSc in Epidemiology from the Harvard School of Public Health, and MPhil in literature from Oxford University. He completed his oncology training at Memorial Sloan-Kettering Cancer Center, where he served on the faculty until taking up his current post at the University of North Carolina.

About Self Care Catalysts, Inc.
Self Care Catalysts is a patient solutions, intelligence, and analytics company deriving value from patient-centered real world evidence designed to inform care management, treatment decisions, product life cycle management and behavior change interventions. More information may be obtained at https://www.selfcarecatalysts.com/.

View original content:http://www.prnewswire.com/news-releases/self-care-catalysts-welcomes-dr-ethan-basch-as-medical-advisor-300782675.html

SOURCE Self Care Catalysts Inc